These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 1642781)
1. [Serological screening for Trypanosoma cruzi among blood donors in central Brazil]. de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F Bol Oficina Sanit Panam; 1992 Jul; 113(1):19-27. PubMed ID: 1642781 [TBL] [Abstract][Full Text] [Related]
2. Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F Bull Pan Am Health Organ; 1992; 26(2):157-64. PubMed ID: 1638280 [TBL] [Abstract][Full Text] [Related]
3. [A confirmatory diagnosis of antibodies anti-Trypanosoma cruzi in donors referred by blood banks in Venezuela]. Díaz-Bello Z; Zavala-Jaspe R; Díaz-Villalobos M; Mauriello L; Maekelt A; de Noya BA Invest Clin; 2008 Jun; 49(2):141-50. PubMed ID: 18717262 [TBL] [Abstract][Full Text] [Related]
4. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Silveira-Lacerda EP; Silva AG; Junior SF; Souza MA; Kesper N; Botelho-Filho A; Umezawa ES Vox Sang; 2004 Oct; 87(3):204-7. PubMed ID: 15569074 [TBL] [Abstract][Full Text] [Related]
5. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Galavíz-Silva L; Molina-Garza DP; González-Santos MA; Mercado-Hernández R; González-Galavíz JR; Rosales-Encina JL; Molina-Garza ZJ Am J Trop Med Hyg; 2009 Sep; 81(3):404-6. PubMed ID: 19706904 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for Chagas disease: Part III. Chagas disease in donors to blood banks]. Apt B W; Heitmann G I; Jercic L MI; Jotré M L; Muñoz C del V P; Noemí H I; San Martin V AM; Sapunar P J; Torres H M; Zulantay A I Rev Chilena Infectol; 2008 Aug; 25(4):285-8. PubMed ID: 18769776 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Tobler LH; Contestable P; Pitina L; Groth H; Shaffer S; Blackburn GR; Warren H; Lee SR; Busch MP Transfusion; 2007 Jan; 47(1):90-6. PubMed ID: 17207235 [TBL] [Abstract][Full Text] [Related]
8. [Control of Chagas disease in blood banks in Colombia]. Behrend M; Beltrán M; Restrepo M; Kroeger A Biomedica; 2002 Mar; 22(1):39-45. PubMed ID: 11957362 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707 [TBL] [Abstract][Full Text] [Related]
11. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response. Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Nowicki MJ; Chinchilla C; Corado L; Matsuoka L; Selby R; Steurer F; Mone T; Mendez R; Aswad S Transplantation; 2006 Feb; 81(3):477-9. PubMed ID: 16477238 [TBL] [Abstract][Full Text] [Related]
13. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Pirard M; Iihoshi N; Boelaert M; Basanta P; López F; Van der Stuyft P Transfusion; 2005 Apr; 45(4):554-61. PubMed ID: 15819677 [TBL] [Abstract][Full Text] [Related]
14. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors]. Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of the indirect immunofluorescent (IFAT), ELISA test and the comercial Chagatek test for anti-Trypanosoma cruzi antibodies detection]. Enciso C; Montilla M; Santacruz MM; Nicholls RS; Rodríguez A; Mercado M; Puerta C Biomedica; 2004 Mar; 24(1):104-8. PubMed ID: 15239607 [TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides. Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850 [TBL] [Abstract][Full Text] [Related]
17. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper. Zicker F; Smith PG; Luquetti AO; Oliveira OS Bull World Health Organ; 1990; 68(4):465-71. PubMed ID: 2119903 [TBL] [Abstract][Full Text] [Related]
18. [Chagas disease screening in the blood donor population]. Assal A; Pelletier B; David B; Tiberghien P Bull Soc Pathol Exot; 2009 Dec; 102(5):291-4. PubMed ID: 20131422 [TBL] [Abstract][Full Text] [Related]
19. Blood donor screening for chagas disease--United States, 2006-2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113 [TBL] [Abstract][Full Text] [Related]